126 related articles for article (PubMed ID: 35293082)
1. Thyroid dysfunction incidence and risk factors in Chinese chronic hepatitis B patients treated with pegylated interferon alpha: A long-term follow-up study.
Ma Z; Qin Y; Jia Y; Xie Y; Qi X; Guo Y; He J; Zhang Y; Li F; Yu J; Zhu H; Yang F; Zhang Y; Mao R; Zhang J
J Viral Hepat; 2022 Jun; 29(6):412-419. PubMed ID: 35293082
[TBL] [Abstract][Full Text] [Related]
2. Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?
Kozielewicz D; Zaleśna A; Dybowska D
Expert Opin Drug Saf; 2014 Aug; 13(8):1009-14. PubMed ID: 24930451
[TBL] [Abstract][Full Text] [Related]
3. Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha.
Liu Y; Zheng Y; Lin X; Cao Z; Lu J; Ma L; Ren S; Zheng S; Hu Z; Xu B; Chen X
BMC Endocr Disord; 2023 May; 23(1):115. PubMed ID: 37217910
[TBL] [Abstract][Full Text] [Related]
4. Incidence of and risk factors for thyroid dysfunction during peginterferon α and ribavirin treatment in patients with chronic hepatitis C.
Hwang Y; Kim W; Kwon SY; Yu HM; Kim JH; Choe WH
Korean J Intern Med; 2015 Nov; 30(6):792-800. PubMed ID: 26552454
[TBL] [Abstract][Full Text] [Related]
5. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis.
Kee KM; Lee CM; Wang JH; Tung HD; Changchien CS; Lu SN; Wang PW
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):319-26. PubMed ID: 16460494
[TBL] [Abstract][Full Text] [Related]
7. The incidence and evolution of thyroid dysfunction during interferon-alpha therapy in children with chronic hepatitis B infection.
Kuloglu Z; Kansu A; Berberoglu M; Adiyaman P; Ocal G; Girgin N
J Pediatr Endocrinol Metab; 2007 Feb; 20(2):237-45. PubMed ID: 17396441
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan.
Chang YK; Tseng YT; Chen KH; Chen KT
BMC Endocr Disord; 2019 Apr; 19(1):36. PubMed ID: 30953492
[TBL] [Abstract][Full Text] [Related]
9. Patterns of interferon-alpha-induced thyroid dysfunction vary with ethnicity, sex, smoking status, and pretreatment thyrotropin in an international cohort of patients treated for hepatitis C.
Mammen JS; Ghazarian SR; Rosen A; Ladenson PW
Thyroid; 2013 Sep; 23(9):1151-8. PubMed ID: 23517287
[TBL] [Abstract][Full Text] [Related]
10. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
[TBL] [Abstract][Full Text] [Related]
11. Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy.
Dalgard O; Bjøro K; Hellum K; Myrvang B; Bjøro T; Haug E; Bell H
J Intern Med; 2002 May; 251(5):400-6. PubMed ID: 11982739
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence and clinical characteristics of thyroid disease induced by chronic hepatitis B treated with polyethylene glycol (peg) interferon-alpha].
Chen XF; Chen XP; Ma XJ; Chen WL; Huang J; Luo XD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):117-9. PubMed ID: 23002550
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.
Carella C; Mazziotti G; Morisco F; Manganella G; Rotondi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
J Clin Endocrinol Metab; 2001 May; 86(5):1925-9. PubMed ID: 11344186
[TBL] [Abstract][Full Text] [Related]
15. Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C.
Pavan MH; Pavin EJ; Gonçales FL; Zantut-Wittmann DE; Wittmann DE
Braz J Infect Dis; 2011; 15(5):449-56. PubMed ID: 22230851
[TBL] [Abstract][Full Text] [Related]
16. Thyroid dysfunction in chinese patients with chronic hepatitis C treated with interferon alpha: incidence, long-term outcome and predictive factors.
Yan Z; Fan K; Fan Y; Wang X; Mao Q; Deng G; Wang Y
Hepat Mon; 2012 Sep; 12(9):e6390. PubMed ID: 23087763
[TBL] [Abstract][Full Text] [Related]
17. The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism.
Carella C; Mazziotti G; Morisco F; Rotondi M; Cioffi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
Eur J Endocrinol; 2002 Jun; 146(6):743-9. PubMed ID: 12039693
[TBL] [Abstract][Full Text] [Related]
18. [Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
Kupś-Rzepecka J; Woźniakowska-Gesicka T; Gołabek V
Przegl Lek; 2011; 68(6):311-5. PubMed ID: 22039668
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of thyroid dysfunction in patients with chronić hepatitis C treated with pegylated interferon alpha and ribavirin.
Kozielewicz D; Wietlicka-Piszcz M; Halota W
Przegl Epidemiol; 2017; 71(4):555-569. PubMed ID: 29415534
[TBL] [Abstract][Full Text] [Related]
20. Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study.
Bini EJ; Mehandru S
Arch Intern Med; 2004 Nov; 164(21):2371-6. PubMed ID: 15557418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
